{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:26:23Z","timestamp":1789539983038,"version":"build-2803163510"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12301-7","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T05:32:20Z","timestamp":1767418340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Virologic failure and its determinants among HIV patients progress towards the third 95% global target in Ethiopia: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8707-4963","authenticated-orcid":false,"given":"Animut Takele","family":"Telayneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Derbie","family":"Habtegiorgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalkidan Worku","family":"Mitiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manaye","family":"Meku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getnet Nibret","family":"Alemie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temesgen","family":"Ayenew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejen","family":"Tsegaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wubetu","family":"Woyraw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurilign Abebe","family":"Moges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habtamu","family":"Temesgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"12301_CR1","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery, and monitoring: recommendations for a public health approach. In. Geneva World Health Organ. 2021."},{"key":"12301_CR2","unstructured":"World Health Organization. Consolidated HIV strategic information guidelines: driving impact through program monitoring and management. In. Geneva World Health Organ. 2020."},{"key":"12301_CR3","unstructured":"The joint United Nations programme on HIV\/AIDS (UNAIDS): global HIV & AIDS statistics fact sheet. 2022."},{"key":"12301_CR4","doi-asserted-by":"crossref","unstructured":"Gachara G, Mavhandu LG, Rogawski ET, Manhaeve C, Bessong PO. Evaluating adherence to antiretroviral therapy using pharmacy refill records in a rural treatment site in South Africa. AIDS Res Treat. 2017, 2017.","DOI":"10.1155\/2017\/5456219"},{"key":"12301_CR5","doi-asserted-by":"crossref","unstructured":"Ojo T, Ruan C, Hameed T, Malburg C, Thunga S, Smith J, Vieira D, Snyder A, Tampubolon SJ, Gyamfi J, et al. HIV, tuberculosis, and food insecurity in Africa & Mdash; a syndemics-based scoping review. Int J Environ Res Public Health. 2022;19(3):1101.","DOI":"10.3390\/ijerph19031101"},{"key":"12301_CR6","doi-asserted-by":"crossref","unstructured":"Ayana WG, Ayana M, Dechasa A. Determinants of virologic failure among adult hiv patients on first-line antiretroviral treatment at Oromia, Central Ethiopia: 2022 a Case-control study. 2023.","DOI":"10.21203\/rs.3.rs-3480530\/v1"},{"key":"12301_CR7","doi-asserted-by":"crossref","unstructured":"Luvanda HB, Mukyanuzi EN, Akarro RR. A joint survival model for estimating the association between viral load outcome and survival time to death among HIV\/AIDS patients attending health care and treatment centers in Tanzania. BMC Public Health. 2023;23(1):2091.","DOI":"10.1186\/s12889-023-16977-x"},{"key":"12301_CR8","doi-asserted-by":"crossref","unstructured":"Krishnamoorthy Y, Rehman T, Sakthivel M. Effectiveness of financial incentives in achieving UNAID fast-track 90-90-90 and 95-95-95 target of HIV care continuum: a systematic review and meta-analysis of randomized controlled trials. AIDS Behav. 2021;25:814\u201325.","DOI":"10.1007\/s10461-020-03038-2"},{"key":"12301_CR9","doi-asserted-by":"crossref","unstructured":"Mageda K, Kulemba K, Olomi W, Kapologwe N, Katalambula L, Petrucka P. Determinants of nonsuppression of HIV viral load among children receiving antiretroviral therapy in the Simiyu region: a cross-sectional study. AIDS Res Ther. 2023;20(1):22.","DOI":"10.1186\/s12981-023-00515-1"},{"key":"12301_CR10","doi-asserted-by":"crossref","unstructured":"Tanue EA, Nsagha DS, Theophile NN, Assob JCN. Improving retention in care and promoting adherence to HIV treatment: protocol for a multisite randomized controlled trial of mobile phone text messaging. JMIR Res Protocol. 2020;9(8):e15680.","DOI":"10.2196\/15680"},{"key":"12301_CR11","doi-asserted-by":"crossref","unstructured":"Antonio Antela AR, Josep M. Llibre and Santiago Moreno on behalf of the ret group: redefining therapeutic success in HIV patients: an expert view. J Antimicrob Chemother. 2021;76: 76:2501\u201318.","DOI":"10.1093\/jac\/dkab168"},{"key":"12301_CR12","unstructured":"Ethiopia ministry of health: national consolidated guidelines for comprehensive HIV prevention, care, and treatment. In: In. Edited by control HPa. Ethiopia; 2022."},{"key":"12301_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2147\/IDR.S341392","volume":"15","author":"GT Atnafu","year":"2022","unstructured":"Atnafu GT, Moges NA, Wubie M, Gedif G. Incidence and predictors of viral load suppression after enhanced adherence counseling among HIV-Positive adults in West Gojjam Zone, Amhara Region, Ethiopia. Infect Drug Resist. 2022;15:261\u201374.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"12301_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/jpids\/piaa030","volume":"10","author":"NZ Bitwale","year":"2021","unstructured":"Bitwale NZ, Mnzava DP, Kimaro FD, Jacob T, Mpondo BC, Jumanne S. Prevalence and factors associated with virological treatment failure among children and adolescents on antiretroviral therapy attending HIV\/AIDS care and treatment clinics in Dodoma Municipality, Central Tanzania. J Pediatr Infect Dis Soc. 2021;10(2):131\u201340.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"11","key":"12301_CR15","doi-asserted-by":"publisher","first-page":"e0289095","DOI":"10.1371\/journal.pone.0289095","volume":"18","author":"NM Abera","year":"2023","unstructured":"Abera NM, Alemu TG, Agegnehu CD. Incidence and predictors of virological failure among HIV infected children and adolescents on first-line antiretroviral therapy in East Shewa hospitals, Oromia Region, Ethiopia: a retrospective follow up study. PLoS One. 2023;18(11):e0289095.","journal-title":"PLoS One"},{"issue":"1","key":"12301_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12981-021-00365-9","volume":"18","author":"M Abdu","year":"2021","unstructured":"Abdu M, Walelgn B. Determinant factors for adherence to antiretroviral therapy among adult HIV patients at Dessie referral hospital, South Wollo, Northeast Ethiopia: a case-control study. AIDS Res Ther. 2021;18(1):39.","journal-title":"AIDS Res Ther"},{"issue":"12","key":"12301_CR17","doi-asserted-by":"publisher","first-page":"e0226293","DOI":"10.1371\/journal.pone.0226293","volume":"14","author":"AA Desta","year":"2019","unstructured":"Desta AA, Wubayehu Woldearegay T, Berhe AA, Futwi N, Gebremedhn Gebru G, Godefay H. Immunological recovery, failure and factors associated with CD-4 T-cells progression over time, among adolescents and adults living with HIV on antiretroviral therapy in Northern Ethiopia: a retrospective cross sectional study. PLoS One. 2019;14(12):e0226293.","journal-title":"PLoS One"},{"issue":"9","key":"12301_CR18","doi-asserted-by":"publisher","first-page":"e0257204","DOI":"10.1371\/journal.pone.0257204","volume":"16","author":"B Bayleyegn","year":"2021","unstructured":"Bayleyegn B, Kifle ZD. Geremew d: virological failure and associated factors among children receiving anti-retroviral therapy, Northwest Ethiopia. PLoS One. 2021;16(9):e0257204.","journal-title":"PLoS One"},{"issue":"1","key":"12301_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12887-022-03177-6","volume":"22","author":"ES Chanie","year":"2022","unstructured":"Chanie ES, Muche AA, Gobeza MB, Alemu EM, Addis WD, Azanaw MM, Gebremariam AD, Tesfa D, Engidaw MT, Atikilit G. Half-life time prediction of developing first-line antiretroviral treatment failure and its risk factors among TB and HIV co-infected children in Northwest Ethiopia; multi setting historical follow-up study. BMC Pediatrics. 2022;22(1):114.","journal-title":"BMC Pediatrics"},{"issue":"6","key":"12301_CR20","doi-asserted-by":"publisher","first-page":"e0198686","DOI":"10.1371\/journal.pone.0198686","volume":"13","author":"G Awungafac","year":"2018","unstructured":"Awungafac G, Amin ET, Fualefac A, Takah NF, Agyingi LA, Nwobegahay J, Ondoa P, Njukeng PA. Viral load testing and the use of test results for clinical decision making for HIV treatment in Cameroon: an insight into the clinic-laboratory interface. PLoS One. 2018;13(6):e0198686\u20130198686.","journal-title":"PLoS One"},{"issue":"1","key":"12301_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12981-021-00336-0","volume":"18","author":"A Mesic","year":"2021","unstructured":"Mesic A, Spina A, Mar HT, Thit P, Decroo T, Lenglet A, Thandar MP, Thwe TT, Kyaw AA, Homan T, et al. Predictors of virological failure among people living with HIV receiving first-line antiretroviral treatment in Myanmar: retrospective cohort analysis. AIDS Res Ther. 2021;18(1):16.","journal-title":"AIDS Res Ther"},{"issue":"11","key":"12301_CR22","doi-asserted-by":"publisher","first-page":"e0277018","DOI":"10.1371\/journal.pone.0277018","volume":"17","author":"J Odayar","year":"2022","unstructured":"Odayar J, Malaba TR, Allerton J, Kabanda S, Huang D, Kalombo C, Lesosky M, Myer L. Virologic outcomes after early referral of stable HIV-positive adults initiating art to community-based adherence clubs in Cape Town, South Africa: a randomised controlled trial. PLoS One. 2022;17(11):e0277018.","journal-title":"PLoS One"},{"key":"12301_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/wja.2021.111001","volume":"11","author":"EW Isaac","year":"2021","unstructured":"Isaac EW, Ajani A, Difa AJ, Aremu JT, Oluwaseun OC, Hassan MD. Viral suppression in adult Nigerians in a regional antiretroviral therapy programme: a cross-sectional descriptive study. World J AIDS. 2021;11:1\u201314.","journal-title":"World J AIDS"},{"issue":"2","key":"12301_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3934\/publichealth.2023033","volume":"10","author":"Philip Boakye aAS: prevalence and predictors of viral load suppression in adults living with HIV in the western region of Ghana: a cross-sectional study","year":"2023","unstructured":"Philip Boakye aAS: prevalence and predictors of viral load suppression in adults living with HIV in the western region of Ghana: a cross-sectional study. Aims Public Health. 2023;10(2):469\u201379.","journal-title":"Aims Public Health"},{"issue":"11","key":"12301_CR25","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1089\/aid.2020.0049","volume":"36","author":"P Ondoa","year":"2020","unstructured":"Ondoa P, Kim AA, Boender TS, Zhang G, Kroeze S, Wiener J, Rinke de Wit T, Nkengasong J. Access to HIV viral load testing and antiretroviral therapy switch practices: a multicountry prospective cohort study in Sub-Saharan Africa. AIDS Res Hum Retroviruses. 2020;36(11):918\u201326.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"12301_CR26","doi-asserted-by":"publisher","first-page":"e0126026","DOI":"10.1371\/journal.pone.0126026","volume":"10","author":"Y Teshome Yimer","year":"2015","unstructured":"Teshome Yimer Y, Yalew AW. Magnitude and predictors of anti-retroviral treatment (ART) failure in private health facilities in Addis Ababa, Ethiopia. PLoS One. 2015;10(5):e0126026.","journal-title":"PLoS One"},{"key":"12301_CR27","doi-asserted-by":"crossref","unstructured":"Anito AA, Lenjebo TL, Woticha E, Solomon F. Magnitude of viral load suppression and associated factors among clients on antiretroviral therapy in Public hospitals of Hawassa City administration, Ethiopia. Hiv\/aids-Res Palliative Care. 2022;529\u201338.","DOI":"10.2147\/HIV.S387787"},{"key":"12301_CR28","doi-asserted-by":"crossref","unstructured":"Diress G, Dagne S, Alemnew B, Adane S, Addisu A. Viral load suppression after enhanced adherence counseling and its predictors among high viral load HIV seropositive people in north wollo zone public hospitals, Northeast Ethiopia, 2019: retrospective cohort study. AIDS Res Treat. 2020, 2020.","DOI":"10.1155\/2020\/8909232"},{"issue":"1","key":"12301_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12199-020-00881-6","volume":"25","author":"M Melku","year":"2020","unstructured":"Melku M, Abebe G, Teketel A, Asrie F, Yalew A, Biadgo B, Kassa E, Damtie D, Anlay DZ. Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy. Environ Health Prev Med. 2020;25(1):43.","journal-title":"Environ Health Prev Med"},{"key":"12301_CR30","first-page":"232595822211110","volume":"21","author":"D Mulisa","year":"2022","unstructured":"Mulisa D, Tolossa T, Bayisa L, Abera T, Wakuma B. First-line virologic-based art treatment failure and associated factors among adult HIV positives in Southwest Shoa, Central Ethiopia. J Int Assoc Providers AIDS Care. 2022;21:232595822211110\u201323259582221111080.","journal-title":"J Int Assoc Providers AIDS Care"},{"issue":"5","key":"12301_CR31","doi-asserted-by":"publisher","first-page":"e0196259","DOI":"10.1371\/journal.pone.0196259","volume":"13","author":"GG Hailu","year":"2018","unstructured":"Hailu GG, Hagos DG, Hagos AK, Wasihun AG, Dejene TA. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia. PLoS One. 2018;13(5):e0196259.","journal-title":"PLoS One"},{"issue":"1","key":"12301_CR32","doi-asserted-by":"publisher","first-page":"e068792","DOI":"10.1136\/bmjopen-2022-068792","volume":"13","author":"H Berihun","year":"2023","unstructured":"Berihun H, Bazie GW, Beyene A, Zewdie A, Kebede N. Viral suppression and associated factors among children tested for HIV viral load at Amhara Public health institute, Dessie branch, Ethiopia: a cross-sectional study. BMJ Open. 2023;13(1):e068792.","journal-title":"BMJ Open"},{"key":"12301_CR33","doi-asserted-by":"crossref","unstructured":"Wedajo S, Degu G, Deribew A, Ambaw F. Rate of viral Re-suppression and retention to care among PLHIV on second-line antiretroviral therapy at Dessie Comprehensive Specialized Hospital, Northeast Ethiopia: a retrospective cohort study. Hiv\/aids-Res Palliative Care. 2021;877\u201387.","DOI":"10.2147\/HIV.S323445"},{"issue":"5","key":"12301_CR34","doi-asserted-by":"publisher","first-page":"e0215300","DOI":"10.1371\/journal.pone.0215300","volume":"14","author":"BA Yihun","year":"2019","unstructured":"Yihun BA, Kibret GD, Leshargie CT. Incidence and predictors of treatment failure among children on first-line antiretroviral therapy in amhara region referral hospitals, northwest Ethiopia, 2018: a retrospective study. PLoS One. 2019;14(5):e0215300\u20130215300.","journal-title":"PLoS One"},{"key":"12301_CR35","doi-asserted-by":"crossref","unstructured":"Negash H, Welay M, Legese H, Adhanom G, Mardu F, Tesfay K, Gebrewahd A, Berhe B. Increased virological failure and determinants among HIV patients on highly active retroviral therapy in Adigrat General Hospital. In: Infectious drug resistant. Vol. 13. Northern Ethiopia; 2019 2020:Hospital-based cross-sectional studyp. 1863\u201372.","DOI":"10.2147\/IDR.S251619"},{"issue":"10","key":"12301_CR36","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.3390\/ijerph18105165","volume":"18","author":"GH Shah","year":"2021","unstructured":"Shah GH, Ewetola R, Etheredge G, Maluantesa L, Waterfield K, Engetele E, Kilundu A. Risk factors for TB\/HIV coinfection and consequences for patient outcomes: evidence from 241 clinics in the democratic Republic of Congo. Int J Environ Res Public Health. 2021;18(10):5165.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"12301_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12879-017-2238-7","volume":"17","author":"Y Sinshaw","year":"2017","unstructured":"Sinshaw Y, Alemu S, Fekadu A, Gizachew M. Successful TB treatment outcome and its associated factors among TB\/HIV co-infected patients attending Gondar University referral hospital, Northwest Ethiopia: an institution based cross-sectional study. BMC Infect Dis. 2017;17(1):132.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"12301_CR38","doi-asserted-by":"publisher","first-page":"e0127024","DOI":"10.1371\/journal.pone.0127024","volume":"10","author":"KB Jacobson","year":"2015","unstructured":"Jacobson KB, Moll AP, Friedland GH, Shenoi SV. Successful tuberculosis treatment outcomes among HIV\/TB coinfected patients down-referred from a district hospital to primary health clinics in rural South Africa. PLoS One. 2015;10(5):e0127024.","journal-title":"PLoS One"},{"key":"12301_CR39","doi-asserted-by":"publisher","first-page":"326","DOI":"10.11604\/pamj.2019.33.326.18911","volume":"33","author":"O Mukuku","year":"2019","unstructured":"Mukuku O, Mutombo AM, Kakisingi CN, Musung JM, Wembonyama SO, Luboya ON. Tuberculosis and HIV co-infection in Congolese children: risk factors of death. Pan Afr Med J. 2019;33:326.","journal-title":"Pan Afr Med J"},{"key":"12301_CR40","first-page":"157","volume":"15","author":"E Erjino","year":"2023","unstructured":"Erjino E, Abera E, Lemma Tirore L. Time to viral load suppression and its predictors among adult patients on antiretro viral therapy in Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Hossana, Southern Ethiopia. HIV AIDS (auckl). 2023;15:157\u201371.","journal-title":"HIV AIDS (auckl)"},{"key":"12301_CR41","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2147\/HIV.S367677","volume":"14","author":"RT Zakaria HF","year":"2022","unstructured":"Zakaria HF RT, Hassen FA, Ayana GM, Merga BT, Debele GR, Kiflemariam G, Kebede SA, Ayele TA. Incidence and predictors of virological failure among adult HIV\/AIDS patients on second-line anti-retroviral therapy, in selected public hospital of Addis Ababa, Ethiopia: retrospective follow-up study. HIV\/aids - Res Palliative Care. 2022;14:319\u201329.","journal-title":"HIV\/aids - Res Palliative Care"},{"key":"12301_CR42","first-page":"457","volume":"15","author":"A Abie","year":"2023","unstructured":"Abie A, Damessa M. The influence of age-associated comorbidities on responses to combination antiretroviral therapy among people living with HIV, at the art clinic of Jimma medical Center, Ethiopia: a hospital-based nested Case-control study. HIV\/AIDS (auckl). 2023;15:457\u201375.","journal-title":"HIV\/AIDS (auckl)"},{"key":"12301_CR43","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2147\/HIV.S281672","volume":"12","author":"IJ Abdullahi","year":"2020","unstructured":"Abdullahi IJ, Deybasso HA, Adlo AM. Determinants of virological failure among patients on first-line antiretroviral therapy in central oromia, Ethiopia: a case-control study. HIV\/aids - Res Palliative Care. 2020;12:931\u201339.","journal-title":"HIV\/aids - Res Palliative Care"},{"key":"12301_CR44","doi-asserted-by":"crossref","unstructured":"Addisu T, Tilahun M, Wedajo S, Sharew B. Trends analysis of HIV infection and antiretroviral treatment outcome in amhara regional from 2015 to 2021, Northeast Ethiopia. Hiv\/aids-Res Palliative Care. 2023;399\u2013410.","DOI":"10.2147\/HIV.S411235"},{"issue":"1","key":"12301_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12879-019-4170-5","volume":"19","author":"YM Bezabih","year":"2019","unstructured":"Bezabih YM, Beyene F, Bezabhe WM. Factors associated with first-line antiretroviral treatment failure in adult HIV-positive patients: a case-control study from Ethiopia. BMC Infect Dis. 2019;19(1):537\u2013537.","journal-title":"BMC Infect Dis"},{"key":"12301_CR46","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE. The PRISMA, 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.","journal-title":"Int J Surg"},{"key":"12301_CR47","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000."},{"issue":"1","key":"12301_CR48","first-page":"1","volume":"2","author":"J Peterson","year":"2011","unstructured":"Peterson J, Welch V, Losos M, Tugwell P. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa: Ottawa Hosp Res Inst. 2011;2(1):1\u201312.","journal-title":"Ottawa: Ottawa Hosp Res Inst"},{"issue":"7414","key":"12301_CR49","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"7109","key":"12301_CR50","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"key":"12301_CR51","doi-asserted-by":"crossref","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;1088\u2013101.","DOI":"10.2307\/2533446"},{"key":"12301_CR52","doi-asserted-by":"publisher","first-page":"d549","DOI":"10.1136\/bmj.d549","volume":"342","author":"R Riley","year":"2011","unstructured":"Riley R, Higgins J, Deeks J. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549. In.","journal-title":"BMJ"},{"issue":"1","key":"12301_CR53","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","volume":"172","author":"JP Higgins","year":"2009","unstructured":"Higgins JP, Thompson SG. Spiegelhalter DJ: a re-evaluation of random-effects meta-analysis. J R Stat Soc: Ser A (stat Soc). 2009;172(1):137\u201359.","journal-title":"J R Stat Soc: Ser A (stat Soc)"},{"key":"12301_CR54","unstructured":"Sosina Mideksa: viral load suppression and associated factors among HIV\/AIDS patients on art in Addis Ababa. Ethiopia Addis Ababa University; 2021."},{"key":"12301_CR55","doi-asserted-by":"crossref","unstructured":"Hailu D, Jara D, Edin A, Awol A, Angefa Ayele A, du Y F, Endale D, Gelchu M, Lemma K. Viral load suppression and associated factors among HIV infected patients on second-line antiretroviral therapy at public health facilities of west Guji. Southern Ethiopia: Guji and Borena zones: Facility based cross-sectional study. 2023.","DOI":"10.1101\/2024.04.02.24305217"},{"key":"12301_CR56","unstructured":"Getaneh Y. GEA, Kidist Zealiyas K., Rahel Tilahun T., Mulu Girma M., Gebremedihin G\/Michael G., Deressa T., Abate E., Kassa D., and Assefa A., PhD.: treatment failure among people living with HIV taking antiretroviral therapy in Ethiopia. 2017."},{"key":"12301_CR57","doi-asserted-by":"crossref","unstructured":"Abebaw A, Taddele M, Alem G, Birlew T. Magnitude of virologic failure and associated factors among adult patients on antiretroviral therapy at Debre Markos referral hospital. Northwest Ethiopia. 2018, 2020.","DOI":"10.21203\/rs.2.20845\/v1"},{"key":"12301_CR58","unstructured":"Belay YD, Moges NA, Teshome M, Tefera KT. The effect of appointment spacing model of care on virological suppression and associated factors among HIV positive individuals on antiretroviral therapy at public health facilities of Debre Markos town, northwest Ethiopia: interrupted time series design. 2020."},{"key":"12301_CR59","doi-asserted-by":"crossref","unstructured":"Getaneh Y, Ning F, He Q, Rashid A, Kassa D, Assefa Y, Yi F, Liao L, Shao Y. Survival and predictors of mortality among adults initiating highly active antiretroviral therapy in Ethiopia: a retrospective cohort study (2007-2019). Biomed Res Int. 2022, 2022: 5884845.","DOI":"10.1155\/2022\/5884845"},{"issue":"5","key":"12301_CR60","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/QAI.0000000000002908","volume":"89","author":"DA Arimide","year":"2022","unstructured":"Arimide DA, Amogne MD, Kebede Y, Balcha TT, Adugna F, Ramos A, DeVos J, Zeh C, Agardh A, Chih-Wei Chang J, et al. High level of HIV drug resistance and virologic nonsuppression among female sex workers in Ethiopia: a nationwide cross-sectional study. J Acquir Immune Defic Syndr. 2022;89(5):566\u201374.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"12301_CR61","doi-asserted-by":"publisher","first-page":"e0257059","DOI":"10.1371\/journal.pone.0257059","volume":"16","author":"I Ahmed","year":"2021","unstructured":"Ahmed I, Demissie M, Worku A, Gugsa S, Berhane Y. Virologic outcomes of people living with human immunodeficiency virus who started antiretroviral treatment on the same-day of diagnosis in Ethiopia: a multicenter observational study. PLoS One. 2021;16(9):e0257059.","journal-title":"PLoS One"},{"issue":"1","key":"12301_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13052-021-01030-7","volume":"47","author":"B Gelaw","year":"2021","unstructured":"Gelaw B, Mulatu G, Tesfa G, Marew C, Chekole B, Alebel A. Magnitude and associated factors of virological failure among children on art in Bahir Dar Town public health facilities, Northwest Ethiopia: a facility based cross-sectional study. Italian J Pediatrics. 2021;47(1):1\u201384.","journal-title":"Italian J Pediatrics"},{"issue":"1","key":"12301_CR63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12981-021-00353-z","volume":"18","author":"KL Workie","year":"2021","unstructured":"Workie KL, Birhan TY, Angaw DA. Predictors of mortality rate among adult HIV-positive patients on antiretroviral therapy in Metema Hospital, Northwest Ethiopia: a retrospective follow-up study. AIDS Res Ther. 2021;18(1):27.","journal-title":"AIDS Res Ther"},{"issue":"8","key":"12301_CR64","doi-asserted-by":"publisher","first-page":"e10169","DOI":"10.1016\/j.heliyon.2022.e10169","volume":"8","author":"T Kiros","year":"2022","unstructured":"Kiros T, Taye A, Workineh L, Eyayu T, Damtie S, Hailemichael W, Tiruneh T. Immuno-virological status and its associated factors among HIV-positive patients receiving highly active antiretroviral therapy at delgi primary hospital, northwest Ethiopia, 2020\/2021: A cross-sectional study. Heliyon. 2022;8(8):e10169\u201310169.","journal-title":"Heliyon"},{"issue":"12","key":"12301_CR65","doi-asserted-by":"publisher","first-page":"e064354","DOI":"10.1136\/bmjopen-2022-064354","volume":"12","author":"EB Wondifraw","year":"2022","unstructured":"Wondifraw EB, Tebeje NB, Akanaw W, Chanie ES. Predictors of first-line antiretroviral treatment failure among children on antiretroviral therapy at the University of Gondar comprehensive specialised hospital, north-west, Ethiopia: a 14-year long-term follow-up study. BMJ Open. 2022;12(12):e064354.","journal-title":"BMJ Open"},{"key":"12301_CR66","first-page":"209","volume":"15","author":"D Endalamaw Alamneh","year":"2023","unstructured":"Endalamaw Alamneh D, Shiferaw MB, Getachew Demissie M, Emiru MA, Zemene Kassie T, Endaylalu Lakew K, Tadege TZ. Virological outcomes among pregnant women receiving antiretroviral treatment in the Amhara Region, North West Ethiopia. HIV AIDS (auckl). 2023;15:209\u201316.","journal-title":"HIV AIDS (auckl)"},{"issue":"5","key":"12301_CR67","doi-asserted-by":"publisher","first-page":"e0303243","DOI":"10.1371\/journal.pone.0303243","volume":"19","author":"MB Belete","year":"2024","unstructured":"Belete MB, Bitew A, Mulatu K. Viral load suppression and its predictor among HIV seropositive people who receive enhanced adherence counseling at public health institutions in Bahir Dar, Northwest Ethiopia. Retrospective follow-up study. PLoS One. 2024;19(5):e0303243.","journal-title":"PLoS One"},{"issue":"5","key":"12301_CR68","doi-asserted-by":"publisher","first-page":"e0197145","DOI":"10.1371\/journal.pone.0197145","volume":"13","author":"KA Atalell","year":"2018","unstructured":"Atalell KA, Birhan Tebeje N, Ekubagewargies DT. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar comprehensive specialized hospital, Northwest Ethiopia. A retrospective follow-up study. PLoS One. 2018;13(5):e0197145.","journal-title":"PLoS One"},{"key":"12301_CR69","first-page":"393","volume":"12","author":"T Fentie Wendie","year":"2020","unstructured":"Fentie Wendie T, Workneh BD. Prevalence and predictors of virological failure among adults living with HIV in South Wollo Zone, Northeast Ethiopia: a retrospective cohort study. HIV\/AIDS (auckl). 2020;12:393\u2013402.","journal-title":"HIV\/AIDS (auckl)"},{"issue":"1","key":"12301_CR70","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12879-019-4058-4","volume":"19","author":"MB Shiferaw","year":"2019","unstructured":"Shiferaw MB, Endalamaw D, Hussien M, Agegne M, Amare D, Estifanos F, Temesgen D. Viral suppression rate among children tested for HIV viral load at the Amhara Public health institute, Bahir Dar, Ethiopia. BMC Infect Dis. 2019;19(1):419.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"12301_CR71","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s13104-019-4429-3","volume":"12","author":"M Alene","year":"2019","unstructured":"Alene M, Awoke T, Yenit MK, Tsegaye AT, Yismaw L, Yeshambel R. Second-line antiretroviral therapy regimen change among adults living with HIV in Amhara region: a multi-centered retrospective follow-up study. BMC Res Notes. 2019;12(1):407.","journal-title":"BMC Res Notes"},{"issue":"1","key":"12301_CR72","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1038\/s41598-024-53569-0","volume":"14","author":"NS Muhie","year":"2024","unstructured":"Muhie NS. Predictors for viral load suppression among HIV positive adults under art treatment in University of Gondar comprehensive specialized hospital: retrospective cohort study. Sci Rep. 2024;14(1):3258.","journal-title":"Sci Rep"},{"key":"12301_CR73","doi-asserted-by":"publisher","first-page":"1249957","DOI":"10.3389\/fped.2024.1249957","volume":"12","author":"EB Abebe","year":"2024","unstructured":"Abebe EB, Gebregeorgis ME, Seid FA, Zemariam AB, Dejene TM, Masresha SA. Incidence and predictors of virological failure among children receiving first-line anti-retroviral treatment in public comprehensive specialized hospitals found in Northeast Ethiopia: a retrospective follow-up study. Front Pediatrics. 2024;12:1249957.","journal-title":"Front Pediatrics"},{"key":"12301_CR74","doi-asserted-by":"crossref","unstructured":"Zenebe E, Washo A. Addis gesese a: time to first-line antiretroviral treatment failure and its predictors among HIV-Positive children in Shashemene Town Health Facilities, Oromia Region, Ethiopia, 2019. Sci World J. 2021, 2021;8868479.","DOI":"10.1155\/2021\/8868479"},{"key":"12301_CR75","unstructured":"Sado AG, Chakso SW-M, Obsie GW. Human immunodeficiency virus viral load suppression and associated factors among client on anti-retroviral therapy in Asella Teaching and referral hospital. Int J Public Health. 2022;11(3)."},{"key":"12301_CR76","doi-asserted-by":"crossref","unstructured":"Waju B, Dube L, Ahmed M, Assefa SS. Unsuppressed viral load level in public health facilities: nonvirological predictors among adult antiretroviral therapy users in southwestern Ethiopia. Hiv\/aids-Res Palliative Care. 2021;513\u201326.","DOI":"10.2147\/HIV.S304653"},{"issue":"4","key":"12301_CR77","first-page":"158","volume":"15","author":"T Haile","year":"2021","unstructured":"Haile T, Hawulte B, Alemayehu S. A retrospective cross-sectional study on the prevalence and factors associated with virological non-suppression among HIV-positive adult patients on antiretroviral therapy in Woliso Town, Oromia, Ethiopia. Int J Med Health Sci. 2021;15(4):158\u201364.","journal-title":"Int J Med Health Sci"},{"key":"12301_CR78","doi-asserted-by":"crossref","unstructured":"Mamo A, Assefa T, Negash W, Takelign Y, Sahiledinigl B, Teferu Z, Mohammed M, Solomon D, Gezahegn H, Bekele K. Virological and immunological antiretroviral treatment failure and predictors among HIV positive adult and adolescent clients in southeast Ethiopia. HIV\/AIDS-Res Palliative Care. 2022;73\u201385.","DOI":"10.2147\/HIV.S354716"},{"key":"12301_CR79","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2334-14-181","volume":"14","author":"A Abdissa","year":"2014","unstructured":"Abdissa A, Yilma D, Fonager J, Audelin AM, Christensen LH, Olsen MF, Tesfaye M, Kaestel P, Girma T, Aseffa A, et al. Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia. BMC Infect Dis. 2014;14:181.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"12301_CR80","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5114\/hivar.2020.96388","volume":"19","author":"H Ayeno","year":"2020","unstructured":"Ayeno H, Imer A. First-line antiretroviral treatment failure and associated factors in HIV patients following highly active antiretroviral therapy at the Shashemene Referral Hospital, Oromia region, Ethiopia. HIV AIDS Rev. 2020;19(2):125\u201331.","journal-title":"HIV AIDS Rev"},{"issue":"2","key":"12301_CR81","first-page":"179","volume":"30","author":"HA Gesesew","year":"2020","unstructured":"Gesesew HA, Ward P, Woldemichael K, Mwanri L. HIV care continuum outcomes: can Ethiopia meet the UNAIDS 90-90-90 targets? Ethiop J Health Sci. 2020;30(2):179\u201388.","journal-title":"Ethiop J Health Sci"},{"key":"12301_CR82","doi-asserted-by":"crossref","unstructured":"Osman FT, Yizengaw MA. Virological failure and associated risk factors among HIV\/AIDS pediatric patients at the ART clinic of Jimma University medical Center, Southwest Ethiopia. The Open AIDS J. 2020;14(1).","DOI":"10.2174\/1874613602014010061"},{"key":"12301_CR83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1874431101812010011","volume":"12","author":"A Sorsa","year":"2018","unstructured":"Sorsa A. Clinical, immunological and virological responses of zidovudine-lamivudine-nevirapine versus zidovudine-lamivudine-efavirenz antiretroviral treatment (art) among HIV-1 infected children: Asella teaching and referral hospital, South-East Ethiopia. The Open Med Inf J. 2018;12:11.","journal-title":"The Open Med Inf J"},{"key":"12301_CR84","doi-asserted-by":"crossref","unstructured":"Ali JH, Yirtaw TG Time to viral load suppression and its associated factors in cohort of patients taking antiretroviral treatment in East Shewa zone, BMC infect dis. Vol. 19(1): Oromiya, Ethiopia,2018. 2019. p. 1084.","DOI":"10.1186\/s12879-019-4702-z"},{"key":"12301_CR85","doi-asserted-by":"crossref","unstructured":"Mosisa Y, Ewunetu A, Duftu KB, Biru B, Diriba D, Shama AT, Lemi M, Fetensa G, Feyisa BR. Predictors of HIV viral load suppression after enhanced adherence counseling, Nekemte, Ethiopia. J Epidemiol Global Health. 2024;1\u20138.","DOI":"10.1007\/s44197-024-00246-0"},{"key":"12301_CR86","unstructured":"Tachbele E, Kyobe S, Fred A, Kigozi E, Mwesigwa S, Joloba M, Amogne W, Legesse M, Peiper R, Ameni G. Prevalence and determinants of virological failure among adult antiretroviral treatment experienced HIV-1 patients in south omo, Ethiopia. Ethiopian J Health Devel. 2022;36(1)."},{"key":"12301_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/2498025","volume":"2021","author":"DA Fenta","year":"2021","unstructured":"Fenta DA, Wube TB, Nuru MM. Long-term immunological and virological outcomes in children receiving highly active antiretroviral therapy at Hawassa University college of medicine and health sciences, southern Ethiopia. J Immunol Res. 2021;2021:1\u20139.","journal-title":"J Immunol Res"},{"key":"12301_CR88","doi-asserted-by":"crossref","unstructured":"Mena ZB, Wolka E, Dana T, Asmare G, Mena MB, Lerango TL. Incidence and predictors of treatment failure among children with HIV on first-line antiretroviral therapy in Wolaita zone, Southern Ethiopia: a multicenter retrospective cohort study. Heliyon. 2023;9(10).","DOI":"10.1016\/j.heliyon.2023.e20737"},{"issue":"6","key":"12301_CR89","first-page":"751","volume":"29","author":"S Hussen","year":"2019","unstructured":"Hussen S, Mama M, Mekonnen B, Yihune M, Shegaze M, Boti N, Shure M. Predictors of time to viral load suppression of adult PLWHIV on art in Arba Minch General Hospital: a follow up study. Ethiop J Health Sci. 2019;29(6):751\u201358.","journal-title":"Ethiop J Health Sci"},{"issue":"3","key":"12301_CR90","doi-asserted-by":"publisher","first-page":"e0249085","DOI":"10.1371\/journal.pone.0249085","volume":"16","author":"E Tekliye","year":"2021","unstructured":"Tekliye E, Alemayehu T, Bacha T. Clinical, immunologic and virologic outcomes of children and adolescents receiving second line anti-retroviral therapy in two referral hospitals in Addis Ababa, Ethiopia. PLoS One. 2021;16(3):e0249085\u20130249085.","journal-title":"PLoS One"},{"issue":"1","key":"12301_CR91","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12985-023-02176-y","volume":"20","author":"GW Tafere","year":"2023","unstructured":"Tafere GW, Hunduma F, Yesuf A. Viral suppression rate at operation triple zero (Otz) and regular art follow-up programs and associated factors among adolescent clients of Addis Ababa Ethiopia: a comparative cross-sectional study. Virol J. 2023;20(1):208.","journal-title":"Virol J"},{"key":"12301_CR92","doi-asserted-by":"crossref","unstructured":"Andarge DE HH, Menna T. Incidence, survival time and associated factors of virological failure among adult HIV\/AIDS patients on first line antiretroviral therapy in st. Paul\u2019s hospital millennium medical college: a retrospective cohort study. PLoS One. 2022;17(10).","DOI":"10.1371\/journal.pone.0275204"},{"key":"12301_CR93","doi-asserted-by":"crossref","unstructured":"Haile GS, Berha AB. Predictors of treatment failure, time to switch and reasons for switching to second line antiretroviral therapy in HIV infected children receiving first line anti-retroviral therapy at a tertiary care hospital in Ethiopia. BMC Pediatrics. 2019;19(1):37\u201337.","DOI":"10.1186\/s12887-019-1402-1"},{"key":"12301_CR94","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijso.2020.08.001","volume":"26","author":"DG Demsie","year":"2020","unstructured":"Demsie DG, Bantie AT, Allene MD, Alema NM, Gebrie D. Antiretroviral treatment failure among HIV-positive adults taking first-line therapy and associated risk factors at adigrat General hospital, Adigart, Ethiopia, 2019: a cross sectional study. Int J Surg Open. 2020;26:16\u201321.","journal-title":"Int J Surg Open"},{"key":"12301_CR95","doi-asserted-by":"crossref","unstructured":"Sibhat M, Kassa M, Gebrehiwot HIncidence and predictors of treatment failure among children receiving first-line antiretroviral treatment in general hospitals of two zones, Pediatric health, medicine and therapeutics. Tigray, Ethiopia; 2019 2020. p. 85\u201394.","DOI":"10.2147\/PHMT.S243656"},{"issue":"9","key":"12301_CR96","doi-asserted-by":"publisher","first-page":"e0239191","DOI":"10.1371\/journal.pone.0239191","volume":"15","author":"A Zenebe Haftu","year":"2020","unstructured":"Zenebe Haftu A, Desta AA, Bezabih NM, Bayray Kahsay A, Kidane KM, Zewdie Y, Woldearegay TW. Incidence and factors associated with treatment failure among HIV infected adolescent and adult patients on second-line antiretroviral therapy in public hospitals of Northern Ethiopia: multicenter retrospective study. PLoS One. 2020;15(9):e0239191.","journal-title":"PLoS One"},{"issue":"1","key":"12301_CR97","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12879-019-4732-6","volume":"20","author":"AA Desta","year":"2020","unstructured":"Desta AA, Woldearegay TW, Futwi N, Gebrehiwot GT, Gebru GG, Berhe AA, Godefay H. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study. BMC Infect Dis. 2020;20(1):4.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"12301_CR98","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/tropicalmed8080391","volume":"8","author":"A Gemechu","year":"2023","unstructured":"Gemechu A, Mihret A, Atire FA, Aseffa A, Howe R, Seyoum B, Mulu A. Virological non-suppression among newly diagnosed HIV-Positive individuals on dolutegravir-based antiretroviral treatment in Eastern Ethiopia: follow-up study. Trop Med Infect Disease. 2023;8(8):391.","journal-title":"Trop Med Infect Disease"},{"issue":"1","key":"12301_CR99","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1186\/s12889-020-09418-6","volume":"20","author":"A Alebel","year":"2020","unstructured":"Alebel A, Engeda EH, Kelkay MM, Petrucka P, Kibret GD, Wagnew F, Asmare G, Bitew ZW, Ketema DB, Gedif G, et al. Mortality rate among HIV-positive children on art in Northwest Ethiopia: a historical cohort study. BMC Public Health. 2020;20(1):1303.","journal-title":"BMC Public Health"},{"issue":"1","key":"12301_CR100","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1186\/s12887-022-03693-5","volume":"22","author":"GG Alemu","year":"2022","unstructured":"Alemu GG, Nigussie ZM, Amlak BT. Achamyeleh AA: survival time and predictors of death among HIV infected under five children after initiation of anti -retroviral therapy in west amhara referral hospitals, Northwest Ethiopia. BMC Pediatr. 2022;22(1):670.","journal-title":"BMC Pediatr"},{"issue":"5","key":"12301_CR101","doi-asserted-by":"publisher","first-page":"e0251648","DOI":"10.1371\/journal.pone.0251648","volume":"16","author":"A Aemro","year":"2021","unstructured":"Aemro A, Wassie M, Chekol B. Incidence and predictors of mortality within the first year of antiretroviral therapy initiation at Debre-Markos referral hospital, Northwest Ethiopia: a retrospective follow up study. PLoS One. 2021;16(5):e0251648.","journal-title":"PLoS One"},{"issue":"9","key":"12301_CR102","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/cid\/civ556","volume":"61","author":"TS Boender","year":"2015","unstructured":"Boender TS, Sigaloff KC, McMahon JH, Kiertiburanakul S, Jordan MR, Barcarolo J, Ford N, Rinke de Wit TF, Bertagnolio S. Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low-and middle-income countries: a systematic review and meta-analysis. Clin Infect Dis. 2015;61(9):1453\u201361.","journal-title":"Clin Infect Dis"},{"key":"12301_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-8160-8","volume":"20","author":"A Endalamaw","year":"2020","unstructured":"Endalamaw A, Mekonnen M, Geremew D, Yehualashet FA, Tesera H, Habtewold TD. HIV\/AIDS treatment failure and associated factors in Ethiopia: meta-analysis. BMC Public Health. 2020;20:1\u201312.","journal-title":"BMC Public Health"},{"issue":"4","key":"12301_CR104","doi-asserted-by":"publisher","first-page":"e0174767","DOI":"10.1371\/journal.pone.0174767","volume":"12","author":"F Taieb","year":"2017","unstructured":"Taieb F, Madec Y, Cournil A, Delaporte E. Virological success after 12 and 24 months of antiretroviral therapy in sub-saharan Africa: comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis. PLoS One. 2017;12(4):e0174767.","journal-title":"PLoS One"},{"key":"12301_CR105","doi-asserted-by":"crossref","unstructured":"Zhao S, Wang W, Li S, He J, Duan W, Fang Z, Ma X, Li Z, Guo C, Wang W. The prevalence of Low-level Viraemia and its association with virological failure in people living with HIV: a systematic review and meta-analysis. 2024.","DOI":"10.2139\/ssrn.4853326"},{"issue":"5","key":"12301_CR106","doi-asserted-by":"publisher","first-page":"e0284405","DOI":"10.1371\/journal.pone.0284405","volume":"18","author":"D Niu","year":"2023","unstructured":"Niu D, Tang H, Chen F, Zhao D, Zhao H, Hou Y, Wang S, Lyu F. Treatment failure and associated factors among people living with HIV on highly active antiretroviral therapy in mainland China: a systematic review and meta-analysis. PLoS One. 2023;18(5):e0284405.","journal-title":"PLoS One"},{"key":"12301_CR107","unstructured":"Ethipian Public Health Institute. Current progress towards 90-90-90 HIV treatment achievement and exploration of challenges faced in Ethiopia. In.; 2020."},{"issue":"1","key":"12301_CR108","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12879-023-08604-2","volume":"24","author":"E Mboggo","year":"2024","unstructured":"Mboggo E, Mtisi E, Mushy SE, Mkawe S, Ngalesoni F, Muya A, Kilimba E, Kamugumya D, Mlay BS. Determinants of viral load suppression failure among HIV adults on ARV attending health care facilities: a retrospective study in Tanga region, Tanzania. BMC Infect Dis. 2024;24(1):312.","journal-title":"BMC Infect Dis"},{"key":"12301_CR109","doi-asserted-by":"crossref","unstructured":"Quaker as SLaMS: trend and factors associated with nonsuppression of viral load among adolescents on art in Tanzania: 2018-2021. Frontires Reprod Health. 2024;6.","DOI":"10.3389\/frph.2024.1309740"},{"issue":"3","key":"12301_CR110","doi-asserted-by":"publisher","first-page":"e0001007","DOI":"10.1371\/journal.pgph.0001007","volume":"3","author":"R Masaba","year":"2023","unstructured":"Masaba R, Woelk G, Siamba S, Ndimbii J, Ouma M, Khaoya J, Kipchirchir A, Ochanda B, Okomo G. Antiretroviral treatment failure and associated factors among people living with HIV on therapy in Homa Bay, Kenya: a retrospective study. PLoS Global Public Health. 2023;3(3):e0001007.","journal-title":"PLoS Global Public Health"},{"issue":"2","key":"12301_CR111","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S2055-6640(20)30466-0","volume":"2","author":"S Rangarajan","year":"2016","unstructured":"Rangarajan S, Colby DJ, Bui DD, Nguyen HH, Tou PB, Danh TT, Tran NBC, Nguyen DA, Nguyen BTH, Doan VTN. Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam. J Virus eradication. 2016;2(2):94\u2013101.","journal-title":"J Virus eradication"},{"key":"12301_CR112","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/1874944501811010135","volume":"11","author":"Mogosetsi NJLHMaGAO: the prevalence of HIV load suppression and related factors among patients on art at phedisong 4 clinic, Pretoria, South Africa","year":"2018","unstructured":"Mogosetsi NJLHMaGAO: the prevalence of HIV load suppression and related factors among patients on art at phedisong 4 clinic, Pretoria, South Africa. The Open Public Health J. 2018;11:135\u201346.","journal-title":"The Open Public Health J"},{"issue":"1","key":"12301_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-023-16453-6","volume":"23","author":"D Fernandez","year":"2023","unstructured":"Fernandez D, Ali H, Pals S, Alemnji G, Vasireddy V, Siberry GK, Oboho I, Godfrey C. Assessing sex differences in viral load suppression and reported deaths using routinely collected program data from PEPFAR-supported countries in sub-saharan Africa. BMC Public Health. 2023;23(1):1\u20139.","journal-title":"BMC Public Health"},{"key":"12301_CR114","first-page":"ofae168","volume-title":"Open Forum infectious diseases: 2024","author":"D Melak","year":"2024","unstructured":"Melak D, Bayou FD, Yasin H, Zerga AA, Wagaye B, Ayele FY, Kebede N, Mekonen AM, Asfaw AH, Tsegaw SA. Virological suppression and its predictors among HIV\/AIDS patients on antiretroviral therapy in Ethiopia: systematic review and meta-analysis. In: Open Forum infectious diseases: 2024. Oxford University Press US; 2024. p. ofae168."},{"key":"12301_CR115","doi-asserted-by":"crossref","unstructured":"Hlophe Ld TJ, Shumba CS. PS N: barriers and facilitators to antiretroviral therapy adherence among adolescents aged 10 to 19 years living with HIV in sub-saharan Africa: a mixed-methods systematic review and meta-analysis. PLoS One. 2023;18(5).","DOI":"10.1371\/journal.pone.0276411"},{"key":"12301_CR116","doi-asserted-by":"crossref","unstructured":"Machila N, Libonda L, Habineza P, Velu RM, Kamboyi HK, Ndhlovu J, Wamunyima I, Sinadambwe MM, Mudenda S, Zyambo C. Prevalence and predictors of virological failure in pediatric patients on HAART in sub-saharan Africa: a systematic review and meta-analysis. Pan Afr Med J. 2023;45(1).","DOI":"10.11604\/pamj.2023.45.98.37017"},{"key":"12301_CR117","doi-asserted-by":"crossref","unstructured":"Boerma RS, Boender TS, Bussink AP, Calis JC, Bertagnolio S, Rinke de Wit TF, Boele van Hensbroek M, Sigaloff KC. Suboptimal viral suppression rates among HIV-infected children in low-and middle-income countries: a meta-analysis. Clin Infect Dis. 2016;ciw645.","DOI":"10.1093\/cid\/ciw645"},{"key":"12301_CR118","doi-asserted-by":"crossref","unstructured":"Ford N, Orrell C, Shubber Z, Apollo T, Vojnov L. HIV viral resuppression following an elevated viral load: a systematic review and meta-analysis. J Int AIDS Soc. 2019;22.","DOI":"10.1002\/jia2.25415"},{"issue":"8","key":"12301_CR119","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/QAD.0b013e328351f5b2","volume":"26","author":"O Ajose","year":"2012","unstructured":"Ajose O, Mookerjee S, Mills EJ, Boulle A, Ford N. Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Aids. 2012;26(8):929\u201338.","journal-title":"Aids"},{"key":"12301_CR120","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2471\/BLT.12.112946","volume":"91","author":"JHM Jhe","year":"2013","unstructured":"Jhe JHM, Bertagnolio S, Kubiakc R, Jordan MR. Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review. Bulletine World Health Organ. 2013;91:377\u201385.","journal-title":"Bulletine World Health Organ"},{"issue":"1","key":"12301_CR121","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12981-024-00630-7","volume":"21","author":"TA kitaw","year":"2024","unstructured":"kitaw TA, Abate BB, Yilak G, Tilahun BD, Faris AM, Walle GT, Haile RN. Virological outcomes of third-line antiretroviral therapy in a global context: a systematic reviews and meta-analysis. AIDS Res Ther. 2024;21(1):43.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"12301_CR122","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s42269-022-00961-3","volume":"46","author":"RD McHomvu","year":"2022","unstructured":"McHomvu RD, Hussein AK, Matee M. Determinants of viral load non-suppression among HIV-positive children and adolescents attending care and treatment clinics in Tabora region, Tanzania. Bull The Natl Res Cent. 2022;46(1):271.","journal-title":"Bull The Natl Res Cent"},{"issue":"8","key":"12301_CR123","doi-asserted-by":"publisher","first-page":"e0289426","DOI":"10.1371\/journal.pone.0289426","volume":"18","author":"PJ Mb\u00e9bi Enon\u00e9","year":"2023","unstructured":"Mb\u00e9bi Enon\u00e9 PJ, Penda CI, Ngondi G, Fokam J, Ebong SB, Mekoulou Ndongo J, Essangui Same EG, Ndjengue Nson LS, Mandengue SH, Eboumbou Moukoko CE. High risk of virologic failure among HIV-infected children and adolescents routinely followed-up in Littoral region of Cameroon. PLoS One. 2023;18(8):e0289426\u20130289426.","journal-title":"PLoS One"},{"key":"12301_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-019-0252-0","volume":"16","author":"J Fokam","year":"2019","unstructured":"Fokam J, Sosso SM, Yagai B, Billong SC, Djubgang Mbadie RE, Kamgaing Simo R, Edimo SV, Nka AD, Tiga Ayissi A, Yimga JF. Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of \u201ctest and treat\u201d. AIDS Res Ther. 2019;16:1\u20138.","journal-title":"AIDS Res Ther"},{"key":"12301_CR125","doi-asserted-by":"crossref","unstructured":"Mabizela SVW, B. Viral suppression among adolescents on HIV treatment in the Sedibeng District, Gauteng province. 2022;45(1):a 2312.","DOI":"10.4102\/curationis.v45i1.2312"},{"issue":"1","key":"12301_CR126","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12981-023-00572-6","volume":"20","author":"S SeyedAlinaghi","year":"2023","unstructured":"SeyedAlinaghi S, Afsahi AM, Moradi A, Parmoon Z, Habibi P, Mirzapour P, Dashti M, Ghasemzadeh A, Karimi E, Sanaati F. Current art, determinants for virologic failure and implications for HIV drug resistance: an umbrella review. AIDS Res Ther. 2023;20(1):74.","journal-title":"AIDS Res Ther"},{"key":"12301_CR127","doi-asserted-by":"crossref","unstructured":"Telayneh A, Tesfa M, Woyraw W, Temesgen H, Alamirew NM, Haile D, Tafere Y, Petrucka P. Time to lost to follow\u2011up and its predictors among adult patients receiving antiretroviral therapy retrospective follow\u2011up study amhara Northwest Ethiopia. Sci Rep. 2022;12.","DOI":"10.1038\/s41598-022-07049-y"},{"issue":"9","key":"12301_CR128","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1177\/0956462420927205","volume":"31","author":"Y Damtie","year":"2020","unstructured":"Damtie Y, Tadese F. Antiretroviral therapy adherence among patients enrolled after the initiation of the universal test and treat strategy in Dessie town: a cross-sectional study. Int J STD AIDS. 2020;31(9):886\u201393.","journal-title":"Int J STD AIDS"},{"key":"12301_CR129","doi-asserted-by":"crossref","unstructured":"Zenu S TT, Reshad M, Abebe E. Determinants of first-line antiretroviral treatment failure among adult patients on treatment in Mettu Karl Specialized Hospital, South West Ethiopia; a case control study. PLoS One. 2021;16(10).","DOI":"10.1371\/journal.pone.0258930"},{"key":"12301_CR130","unstructured":"Dabb TN. Determinants of change in CD4 count and relationship with survival among children with HIV in Ethiopia. AIDS Care. 2020."},{"key":"12301_CR131","doi-asserted-by":"crossref","unstructured":"Ekwaru J, Campbell J, Malamba S, Dm MM, Were W, Mermin J. The effect of opportunistic illness on HIV RNA viral load and CD4 T cell count among HIV-positive adults taking antiretroviral therapy. J Int AIDS Soc. 2013;16.","DOI":"10.7448\/IAS.16.1.17355"},{"key":"12301_CR132","doi-asserted-by":"crossref","unstructured":"Ebissa G, Deyessa N, Biadgilign S. Impact of highly active antiretroviral therapy on nutritional and immunologic status in HIV-infected children in the low-income country of Ethiopi. Nutrition. 2016;32:667\u201373.","DOI":"10.1016\/j.nut.2015.12.035"},{"key":"12301_CR133","doi-asserted-by":"crossref","unstructured":"Kirkoyun Uysal HK, Sarsar KS MO, Erkose P, Genc GY, Ozdemir G, Onel Mm E, Demirci S, M, et al. Distribution of opportunistic pathogens in people living with HIV at a University Hospital in Istanbul over a one-year treatment period and its association with CD4 T cell counts. Pathogens. 2023;12:1226.","DOI":"10.3390\/pathogens12101226"},{"key":"12301_CR134","doi-asserted-by":"crossref","unstructured":"Calderwood CJ, Tlali M, Karat AS, Hoffmann CJ, Charalambous S, Johnson S, Grant AD, Fielding KL. Risk factors for hospitalization or death among adults with advanced HIV at enrollment for care in South Africa: a secondary analysis of the TB fast track trial. Open Forum Infect Dis. 2022;9(7).","DOI":"10.1093\/ofid\/ofac265"},{"key":"12301_CR135","doi-asserted-by":"crossref","unstructured":"Kyamakya MNV. Efficacy of viral load suppression on life expectancy of human immunodeficiency virus patients: a literature review. Int J Community Med Public Health. 2020;7(1).","DOI":"10.18203\/2394-6040.ijcmph20195882"},{"key":"12301_CR136","doi-asserted-by":"crossref","unstructured":"Tewachew A, Mekonnen W, Mekuria A, Amare Y. Determinants of opportunistic infections among HIV-positive patients on HAART in Debre Berhan Referral Hospital, North Shoa Zone, Ethiopia, 2020: a case-control study. HIV\/aids - Res Palliative Care. 2021;13:337\u201347.","DOI":"10.2147\/HIV.S298661"},{"key":"12301_CR137","doi-asserted-by":"crossref","unstructured":"Assefa A, Gelaw B, Getnet G, Yitayew G. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2014;14(1):468.","DOI":"10.1186\/1471-2334-14-468"},{"key":"12301_CR138","doi-asserted-by":"crossref","unstructured":"Ayana GM, Akalu TY, Ayele TA. Joint modeling of incidence of tuberculosis and change in viral load over time among adult HIV\/AIDS patients on anti-retroviral therapy at Zewditu Memorial Hospital in Addis Ababa, Ethiopia. HIV AIDS (auckl). 2021;13:239\u201349.","DOI":"10.2147\/HIV.S291872"},{"key":"12301_CR139","doi-asserted-by":"crossref","unstructured":"Fenner L, Atkinson A, Boulle A, Fox MP, Prozesky H, Z\u00fcrcher K, Ballif M, Furrer H, Zwahlen M, Davies MA. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies. J Int AIDS Soc. 2017;20(1):21327.","DOI":"10.7448\/IAS.20.1.21327"},{"key":"12301_CR140","doi-asserted-by":"crossref","unstructured":"Hussen Tale A, Seyoum Tegegne A, Bitew Belay D. Predictors of viral load and medication adherence among HIV-positive adults under treatment at felege-hiwot comprehensive specialized hospital, North-West, Ethiopia. HIV\/aids - Res Palliative Care. 2023;15:477\u201389.","DOI":"10.2147\/HIV.S422980"},{"key":"12301_CR141","doi-asserted-by":"crossref","unstructured":"Morawej Z, Nyundo A, Kinyaga A, Kirway V, Kagoye S, Turiho A, Nakasujja N. Prevalence and factors associated with substance use among HIV positive youth attending HIV care and treatment centers in Dodoma, Tanzania. AIDS Res Ther. 2022;19(1):65.","DOI":"10.1186\/s12981-022-00485-w"},{"key":"12301_CR142","doi-asserted-by":"crossref","unstructured":"Cachay ER, Moges TS, Qin H, Bamford L, Grelotti DJ, Mathews WC. Effects of drug and hazardous alcohol use on having a detectable HIV viral load: an adherence mediation analysis. Addictive Behaviors Rep. 2023;17:100486.","DOI":"10.1016\/j.abrep.2023.100486"},{"key":"12301_CR143","doi-asserted-by":"crossref","unstructured":"Lesko CR, Keil AP, Fojo AT, Chander G, Lau B, Moore RD. Recent substance use and probability of unsuppressed HIV viral load among persons on antiretroviral therapy in continuity care. Am J Epidemiol. 2019;188(10):1830\u201337.","DOI":"10.1093\/aje\/kwz159"},{"key":"12301_CR144","doi-asserted-by":"crossref","unstructured":"Asrade AA MN, Meseret M, Alemu, KD TT, Petrucka P, et al. Uptake of appointment spacing model of care and associated factors among stable adult HIV clients on antiretroviral treatment Northwest Ethiopia. PLoS One. 2022;17(12).","DOI":"10.1371\/journal.pone.0279760"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12301-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12301-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12301-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T08:02:14Z","timestamp":1767600134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12301-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":144,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12301"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12301-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"7 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}